THE ASSOCIATION OF FINANCIAL HARDSHIP AND HEALTH-RELATED QUALITY OF LIFE AMONG CANCER PATIENTS
Keywords:
QoL, OOPE, EORTCDOI:
https://doi.org/10.17654/0973514325023Abstract
Background: The purpose of this study is to estimate the impact of out-of-pocket expenditure on the quality of life among cancer patients. A study with 133 cancer patients was conducted in North India. The quality of life was assessed using the EORTC-30 questionnaire.
Method: A multiple linear regression model was used to estimate parameters associated with quality of life. Patients who incur no out-of-pocket costs have a higher quality of life than those who do.
Results: The average difference in quality of life ratings is 18.57, with a 95% confidence interval of 11.29 to 25.85. Excessively high cancer care costs and more spending, particularly among the lower economic group, resulted in a poor quality of life.
Conclusion: Patients undergoing out-of-pocket expenses had a lower quality of life, whereas those receiving chemotherapy and radiation therapy had a lower quality of life than those undergoing surgery.
Received: May 31, 2025
Revised: June 30, 2025
Accepted: July 15, 2025
References
[1] I. Soerjomataram and F. Bray, Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070, Nature Reviews Clinical Oncology 18(10) (2021), 663-672.
[2] H. Sung, J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal and F. Bray, Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA: a Cancer Journal for Clinicians 71(3) (2021), 209-249.
[3] K. Sathishkumar, M. Chaturvedi, P. Das, S. Stephen and P. Mathur, Cancer incidence estimates for 2022 and projection for 2025: result from National Cancer Registry Programme, India, Indian Journal of Medical Research 156(4&5) (2022), 598-607.
[4] V. Kulothungan, K. Sathishkumar, S. Leburu, T. Ramamoorthy, S. Stephen, D. Basavarajappa, N. Tomy, R. Mohan, G. R. Menon and P. Mathur, Burden of cancers in India-estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on National Cancer Registry Program, BMC Cancer, 22(1) (2022), 527.
[5] K. Mystakidou, E. Tsilika, E. Parpa, O. Kalaidopoulou, V. Smyrniotis and L. Vlahos, The EORTC core quality of life questionnaire (QLQ‐C30, version 3.0) in terminally ill cancer patients under palliative care: Validity and reliability in a Hellenic sample, International Journal of Cancer 94(1) (2001), 135-139.
[6] S. Sangar, V. Dutt and R. Thakur, Comparative assessment of economic burden of disease about out of pocket expenditure, Frontiers in Public Health 7 (2019), 9.
[7] S. Rajpal, A. Kumar and W. Joe, Economic burden of cancer in India: Evidence from cross-sectional nationally representative household survey, 2014, PloS One 13(2) (2018), e0193320.
[8] V. Kulothungan, K. Sathishkumar, S. Leburu, T. Ramamoorthy, S. Stephen, D. Basavarajappa, N. Tomy, R. Mohan, G. R. Menon and P. Mathur, Burden of cancers in India-estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on National Cancer Registry Program, BMC Cancer 22(1) (2022), 527.
[9] N. Scott, P. Fayers, N. Aaronson, A. Bottomley, A. de Graeff, M. Groenvold, C. Gundy, M. Koller, M. A. Petersen and M. A. G. Sprangers, EORTC QLQ-C30, Reference values, Brussels: EORTC, 2008.
[10] X. Y. Song and S. Y. Lee, Model comparison of generalized linear mixed models, Statistics in Medicine 25(10) (2006), 1685-1698.
[11] B. A. Bell, M. Ene, W. Smiley and J. A. Schoeneberger, A multilevel model primer using SAS PROC MIXED, In SAS Global forum, Vol. 433, Columbia, SC, USA: University of South Carolina, 2013, pp. 1-19.
[12] E. S. Shtatland, S. Moore, I. Dashevsky, I. Miroshnik, E. Cain and M. B. Barton, How to be a Bayesian in SAS: Model selection uncertainty in PROC, 2000.
[13] E. S. Shtatland, S. Moore, I. Dashevsky, I. Miroshnik, E. Cain and M. B. Barton, How to be a Bayesian in SAS: Model selection uncertainty in PROC LOGISTIC and PROC GENMOD, In Proceedings of the 13th Annual North East SAS Users Group Conference, 2000, pp. 1-9.
[14] G. Basavaiah, P. D. Rent, E. G. Rent, R. Sullivan, M. Towne, M. Bak, B. Sirohi, M. Goel and S. V. Shrikhande, Financial impact of complex cancer surgery in India: a study of pancreatic cancer, Journal of Global Oncology 4 (2018), 1-9.
[15] B. Bose, J. Clarke, J. C. Glasbey, P. D. Haque, K. Jolly, P. A. Kingsley, R. Mittal, D. Morton, R. Oppong, A. Phillips and A. Pipara, Catastrophic Expenditure and Treatment Attrition in Patients Seeking Comprehensive Colorectal Cancer Treatment in India: A Prospective Multicentre Study, The Lancet Regional Health-Southeast Asia, 2022.
[16] V. K. Barwal, A. Thakur, S. R. Mazta and G. A. Sharma, Out-of-pocket expenditure for diagnosis of lung cancer: a significant pretreatment financial burden-study from a tertiary care cancer center in North India, CHRISMED Journal of Health and Research 6(1) (2019), 18-22.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 PUSHPA PUBLISHING HOUSE, PRAYAGRAJ, INDIA
This work is licensed under a Creative Commons Attribution 4.0 International License.
_________________________
Attribution: Credit Pushpa Publishing House as the original publisher, including title and author(s) if applicable.
Non-Commercial Use: For non-commercial purposes only. No commercial activities without explicit permission.
No Derivatives: Modifying or creating derivative works not allowed without written permission.
Contact Puspha Publishing House for more info or permissions.
Journal Impact Factor: 
Publication count: 330
Google h-index: 10
Downloads: 87500+